YARTEMLEASSIST PATIENT SUPPORT PROGRAM Trademark
YARTEMLEASSIST PATIENT SUPPORT PROGRAM is a USPTO trademark filed by Omeros Corporation. Status: Registered.
Trademark Facts
| Mark | YARTEMLEASSIST PATIENT SUPPORT PROGRAM |
|---|---|
| Serial Number | 97462726 |
| Registration Number | 8206166 |
| Status | Registered |
| Filing Date | 2022-06-16 |
| Registration Date | 2026-04-07 |
| Mark Type | Combined |
| Nice Classes | 016 (Paper Goods), 035 (Advertising & Business), 036 (Financial Services), 041 (Education & Entertainment) |
| Owner | Omeros Corporation |
| Attorney of Record | Kelley B. Harrington |
| Prosecution Events | 49 |
| Latest Event | NRCC on 2026-04-07 |
Goods & Services
Educational services, namely, conducting educational programs in the fields of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders and treatment and patient support options for these conditions; Printed publications in the nature of brochures, pamphlets, newsletters, written articles and guidebooks in the field of medical information and patient support; Providing a website featuring financial information regarding medical benefits and reimbursements available for medical expenses related thereto; insurance services, namely, benefits verification in the nature of insurance claims administration; and providing online information and financial assistance with insurance benefits and coverage for health care providers and patients in the field of endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders; Promoting awareness of patient support offerings for endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders; business administration of reimbursement and medical benefit information for endothelial diseases and disorders, renal diseases, transplant complications, ischemia-reperfusion injury and hematological, autoimmune, neurological, immunological and inflammation-related disease and disorders and their treatment; and business administrative services for medical referrals; "PATIENT SUPPORT PROGRAM"